ARC Capital Invests $13 Million in Buchang Pharma Group

ARC Capital Holdings of Hong Kong paid $13 million to acquire a minority interest in Buchang Pharmaceutical Group, a privately-owned TCM company. According to a news release, Buchang is the largest TCM company in China – if the judging standard is net profit. Buchang, which was founded in 1993, includes two hospitals and a university in addition to its portfolio of six pharma entities. More details.... Stock Symbol: (AIM: ARCH)     Share this with colleagues: